Lessons Learned from COVID-19 & Supply Chain Mayhem
Date & Time
Thursday, November 17, 2022, 2:45 PM - 3:30 PM

The FDA and industry have come through an unprecedented period because of the COVID-19 pandemic. The FDA was forced to adapt its approach to manage risk to its own workforce and that of the industry. This session will cover compliance issues and concerns or potential FDA 483 observations resulting from the COVID-19 pandemic, as well as some of the lessons that have been learned by both the FDA and industry.

Jeff Yuen David Chesney
Drugs & Biologics
Location Name
Salon 1-3